KIROMIC BIOPHARMA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBPQ and buy or sell other stocks, ETFs, and their options commission-free!About KRBPQ
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani
CEOPietro Bersani
Employees44
Employees44
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees44
Employees44
KRBPQ Key Statistics
Market cap265.35
Market cap265.35
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume309.11
Average volume309.11
High today—
High today—
Low today—
Low today—
Open price$0.0001
Open price$0.0001
Volume0.00
Volume0.00
52 Week high$1.80
52 Week high$1.80
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 265.35, KIROMIC BIOPHARMA INC(KRBPQ) trades at $0.00.
KIROMIC BIOPHARMA INC(KRBPQ) stock opened on 2025-12-10 at $0.00. The price climbed to — and dipped to —.
KIROMIC BIOPHARMA INC(KRBPQ) shares are trading with a volume of 0, against a daily average of 309.11.
In the last year, KIROMIC BIOPHARMA INC(KRBPQ) shares hit a 52-week high of $1.80 and a 52-week low of $0.00.
In the last year, KIROMIC BIOPHARMA INC(KRBPQ) shares hit a 52-week high of $1.80 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own KRBPQ. This list is generated using Robinhood data, and it’s not a recommendation.